NO161909C - Analogifremgangsmaate for fremstilling av farmasoeytisk anvendelige salter av 3-hydroksy-butansyre. - Google Patents

Analogifremgangsmaate for fremstilling av farmasoeytisk anvendelige salter av 3-hydroksy-butansyre.

Info

Publication number
NO161909C
NO161909C NO830618A NO830618A NO161909C NO 161909 C NO161909 C NO 161909C NO 830618 A NO830618 A NO 830618A NO 830618 A NO830618 A NO 830618A NO 161909 C NO161909 C NO 161909C
Authority
NO
Norway
Prior art keywords
pharmasoyytically
hydroxy
preparation
butanic acid
used salts
Prior art date
Application number
NO830618A
Other languages
English (en)
Norwegian (no)
Other versions
NO830618L (no
NO161909B (no
Inventor
Jacques Lammerant
Jaroslaw Kolanowski
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Publication of NO830618L publication Critical patent/NO830618L/no
Publication of NO161909B publication Critical patent/NO161909B/no
Publication of NO161909C publication Critical patent/NO161909C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO830618A 1982-02-23 1983-02-22 Analogifremgangsmaate for fremstilling av farmasoeytisk anvendelige salter av 3-hydroksy-butansyre. NO161909C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8203100A FR2521857B1 (fr) 1982-02-23 1982-02-23 Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee

Publications (3)

Publication Number Publication Date
NO830618L NO830618L (no) 1983-08-24
NO161909B NO161909B (no) 1989-07-03
NO161909C true NO161909C (no) 1989-10-11

Family

ID=9271331

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830618A NO161909C (no) 1982-02-23 1983-02-22 Analogifremgangsmaate for fremstilling av farmasoeytisk anvendelige salter av 3-hydroksy-butansyre.

Country Status (21)

Country Link
US (2) US4579955A (enExample)
EP (1) EP0087192B1 (enExample)
JP (1) JPS58201746A (enExample)
KR (1) KR910000143B1 (enExample)
AT (1) ATE24478T1 (enExample)
AU (2) AU560757B2 (enExample)
CA (1) CA1203242A (enExample)
DE (1) DE3368601D1 (enExample)
DK (1) DK163235C (enExample)
ES (2) ES8500240A1 (enExample)
FI (1) FI79523C (enExample)
FR (1) FR2521857B1 (enExample)
GR (1) GR77934B (enExample)
IE (1) IE54561B1 (enExample)
IL (1) IL67965A0 (enExample)
MX (1) MX156855A (enExample)
NO (1) NO161909C (enExample)
NZ (1) NZ203279A (enExample)
PH (1) PH21561A (enExample)
PT (1) PT76267A (enExample)
ZA (1) ZA831019B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
US6020007A (en) * 1984-06-22 2000-02-01 Btg International Limited Fluid therapy with l-lactate and/or pyruvate anions
USRE38604E1 (en) 1984-06-22 2004-09-28 Btg International Limited Fluid therapy with L-lactate and/or pyruvate anions
US4777288A (en) * 1987-06-11 1988-10-11 Pfizer Inc. Process for preparing a 4,4-diphenylbutanoic acid derivative
BE1001209A3 (fr) * 1987-11-19 1989-08-22 Solvay Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
US5292774A (en) * 1988-07-26 1994-03-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
DE4113984C2 (de) * 1991-04-29 2002-05-08 Koehler Chemie Dr Franz Salze der 4-Hydroxy-Buttersäure
ES2051222B1 (es) * 1992-03-12 1995-02-16 Sanmiguel Gabriel Serrano Procedimiento de neutralizacion de acido alfa-hidroxietanoico.
JP4598203B2 (ja) 1995-12-01 2010-12-15 ビーティージー・インターナショナル・リミテッド 脳機能改善剤
US6316038B1 (en) 1997-03-17 2001-11-13 Btg International Limited Therapeutic compositions
CA2283642C (en) * 1997-03-17 2012-05-15 Btg International Limited Therapeutic compositions
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US6613356B1 (en) 2000-10-10 2003-09-02 Victor Vlahakos Weight loss medication and method
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
WO2006020137A2 (en) * 2004-07-16 2006-02-23 Ketocytonyx Inc. Oligomeric compounds
WO2006020179A2 (en) * 2004-07-20 2006-02-23 Ketocytonyx Inc. Oligomeric ketone compounds
EP1778212A4 (en) * 2004-07-23 2010-12-08 Btg Int Ltd SACCHARIDES CETOGENES
US20070197645A1 (en) * 2004-09-21 2007-08-23 Martin Keith F Treatment of adhd
ES2574557T3 (es) * 2004-09-21 2016-06-20 Btg International Limited Miméticos dopaminérgicos
RU2302239C1 (ru) * 2006-07-14 2007-07-10 Михаил Владимирович Покровский Способ фармакологической коррекции ишемии конечности
JPWO2008053982A1 (ja) 2006-10-30 2010-02-25 株式会社オフテクス アレルギー治療用組成物
DK2914251T3 (da) 2012-11-05 2019-11-04 Us Health Ketonlegemer til beskyttelse af væv mod beskadigelse som følge af ioniseringsstråling
KR20180088809A (ko) 2015-11-19 2018-08-07 가부시키가이샤 오츠카 세이야쿠 코죠 3-히드록시이소발레르산의 1가 양이온염의 결정 및 그 결정의 제조 방법
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
JP6710098B2 (ja) * 2016-05-10 2020-06-17 大阪瓦斯株式会社 栄養剤組成物及び栄養補助食品
US11098007B2 (en) 2016-06-24 2021-08-24 Kyowa Hakko Bio Co., Ltd. Crystal of amino acid salt of 3-hydroxyisovaleric acid and production method thereof
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
CN112341331B (zh) * 2019-08-07 2023-04-07 辽宁科硕营养科技股份有限公司 一种3-羟基丁酸盐及其制备方法与应用
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
WO2024192165A1 (en) * 2023-03-14 2024-09-19 The Board Of Trustees Of The Leland Stanford Junior University N-beta-hydroxybutyryl-amino acids and related compositions and methods
WO2025056246A1 (en) * 2023-09-11 2025-03-20 Societe Des Produits Nestle S.A. Polymorphs and compositions comprising same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2101097A (en) * 1934-07-26 1937-12-07 Wm S Merrell Co Products for rendering the urine bacteriostatic
US2799684A (en) * 1954-06-18 1957-07-16 Food Chemical And Res Lab Inc Crystalline compounds of tryptophane and methods of manufacturing them
NL279760A (enExample) * 1961-06-17
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
DE2733202A1 (de) * 1976-08-04 1978-02-09 Agroferm Ag Verfahren zur herstellung der d(-)-3-hydroxybuttersaeure
US4412943A (en) * 1981-02-23 1983-11-01 Kao Soap Co., Ltd. Liquid detergent composition
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee

Also Published As

Publication number Publication date
PT76267A (fr) 1983-03-01
CA1203242A (fr) 1986-04-15
GR77934B (enExample) 1984-09-25
AU1162483A (en) 1983-09-01
US4771074A (en) 1988-09-13
MX156855A (es) 1988-10-07
DK81583A (da) 1983-08-24
EP0087192A1 (fr) 1983-08-31
DK163235B (da) 1992-02-10
ES519991A0 (es) 1984-10-01
ATE24478T1 (de) 1987-01-15
ES8500240A1 (es) 1984-10-01
KR910000143B1 (ko) 1991-01-21
FI79523C (fi) 1990-01-10
ZA831019B (en) 1983-11-30
DE3368601D1 (en) 1987-02-05
ES8506283A1 (es) 1985-07-01
AU6916187A (en) 1987-05-21
AU602329B2 (en) 1990-10-11
IE830366L (en) 1983-08-23
PH21561A (en) 1987-12-11
JPS58201746A (ja) 1983-11-24
DK81583D0 (da) 1983-02-23
IL67965A0 (en) 1983-06-15
FR2521857B1 (fr) 1985-10-31
FI830603A0 (fi) 1983-02-23
DK163235C (da) 1992-06-29
ES532880A0 (es) 1985-07-01
IE54561B1 (en) 1989-11-22
KR840003414A (ko) 1984-09-08
EP0087192B1 (fr) 1986-12-30
US4579955A (en) 1986-04-01
FI830603L (fi) 1983-08-24
AU560757B2 (en) 1987-04-16
FI79523B (fi) 1989-09-29
FR2521857A1 (fr) 1983-08-26
NZ203279A (en) 1985-04-30
NO830618L (no) 1983-08-24
NO161909B (no) 1989-07-03

Similar Documents

Publication Publication Date Title
NO161909C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk anvendelige salter av 3-hydroksy-butansyre.
DK162222C (da) 2-amino-5-hydroxy-4-methylpyrimidin-derivater og farmeceutiske praeparater indeholdende disse
RO84704B (ro) Procedeu pentru prepararea unor derivati de n-piperidinil-benzamide
ES2056791T3 (es) Un procedimiento para preparar derivados de pirrolidinamida de acil aminoacido.
ES8801310A1 (es) Un procedimiento para preparar derivados de alanil-protina.
ES8103027A1 (es) Un procedimiento para la preparacion de un polipeptido
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
NZ302072A (en) 1,3-diamino propyl stereomeric derivatives and organic acid and inorganic salts of their amine intermediates in the preparation of retroviral protease inhibitors
PT88086A (pt) Processo para a preparacao de composicoes farmaceuticas a base de sais de alfa-aminoacidos basicos e de alfa-ceto-analogos de aminoacidos de cadeia ramificada apropriadas para o tratamento da uremia
PT92558A (pt) Processo para a preparacao de derivados de aminoacidos inibidores de enzimas e de composicoes farmaceuticas que os contem
FR2575164B1 (fr) Esters de tri- et tetrapeptides inhibiteurs de la secretion gastrique, procede d'obtention et compositions pharmaceutiques les contenant
DOP2001000129A (es) Productos a base de uvas, fortificados con calcio y metodos para prepararlos.
ATA363479A (de) Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ES2037003T3 (es) Procedimiento para preparar peptidos empleando percloratos.
ATE113843T1 (de) Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.
DE3464486D1 (en) Derivatives of n-(4-acetylaminophenacyl)-amine, their therapeutical use and process for their preparation
NO20023107D0 (no) Karboksamid-diazepinderivater, fremstillingsmetode, anvendelse som medisiner, farmasöytiske preparater og anvendelsederav
DK222886A (da) Propionylanilider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser
BR0211780A (pt) Composto, e, composição farmacêutica
ES2075798B1 (es) Derivados de aminoacidos naturales como inhibidores de metaloproteinasas, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y el uso de dichos compuestos en medicina.
FI884634L (fi) Syklopropyylimalonianilaattijohdannaisia sekä tällaista johdannaista sisältävä koostumus käytettäväksi kasvien kasvun hidastamiseksi